Identifying Molecular Markers of Relapse in Myelodysplastic Syndrome.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 12, p. 627
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2018 AND VI 32 AND IP 12
Results: 7
1
2
Immunotherapeutic Approaches to the Management of Head and Neck Cancer.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 12, p. 617
- By:
- Publication type:
- Article
3
COUNTERPOINT: Prostate Cancer Genomic Analysis: Routine or Research Only? Limitations Exist for Guiding Therapeutic Treatment.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 12, p. 607
- By:
- Publication type:
- Article
4
POINT: Prostate Cancer Genomic Analysis: Routine or Research Only? Genomic Testing Should Be Routine in the Management of Prostate Cancer Patients.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 12, p. 607
- By:
- Publication type:
- Article
5
Gonadotropin--Releasing Hormone Antagonists in Prostate Cancer.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 12, p. 599
- By:
- Publication type:
- Article
6
Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 12, p. 591
- By:
- Publication type:
- Article
7
Strategies for the Optimal Management of Dyspnea in Cancer Patients With Advanced Illness.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 12, p. 583
- By:
- Publication type:
- Article